Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis
暂无分享，去创建一个
F. Tacke | A. Geerts | B. Lapauw | J. Krupinski | A. Hoorens | J. Hundertmark | Qihong Zhao | L. Devisscher | E. Charles | F. Van de Velde | B. Zinker | M. Kohlhepp | S. Lefere | Tobias Puengel | C. Penners | Stephanie Boehm